NE
Neuphoria Therapeutics Inc.
NEUP · NASDAQ
$3.73 -0.13% (-$0.00)
1M -2.61%
Market Cap $20.2M
P/E Ratio -
Div. Yield -
ROE 113.35%
Bulios Fair Price
$4.66
24.9% upside
Trenutna cena
$3.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NEUP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/B 0.69x
P/FCF 0.34x
P/S -1.92x
Growth
78 /100
Growing Book val. growth 20.24%
Rev. growth 244.38%
FCF growth N/A
Profitability
70 /100
Strong Net margin 271.98%
Op. margin 230.73%
FCF margin 567.82%
Quality
0 /100
Poor ROE 113.35%
ROA 81.82%
Asset turnover -0.30x
Debt
100 /100
Low Current ratio 14.31x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 92.39%
Profitable years 0
Beta 0.75x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NEUP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Spyridon Papapetropoulos
Employees
8
Headquarters
Burlington
Prihajajoči dogodki
05 OKT.
Earnings
Upcoming earnings report